JP2024510057A - Decontamination procedures for Hakimpur Sina - Google Patents

Abstract

A general serum procedure for all pathogens in which proteins are encoded in the pathogen's outer shell, containing dead pathogens and dead genomes, and eliminating human and animal pathogens and oncogenes. include. Devices that detect pathogens in the human body, animals, plants, water bodies, and the air can detect pathogens in the human body, animals, plants, water bodies, and the atmosphere by observing the spectral signatures emitted from the human body and water bodies without a blood test. pathogens and uses the electrostatic properties of the pathogens and their genomes to capture them.

Description

Conventional treatments for diseases caused by pathogens have been pursued through a variety of methods, such as making serum from animals such as horses and working at the genome level. My invention detects and scans pathogens based on their spectral characteristics without the need for blood tests. Each molecule and pathogen has its own spectrum. I approach therapeutic problems from the electrostatic properties of pathogens. All known pathogens are negatively charged. Genes that cause cancer have either a positive or negative charge. By applying direct current voltage to appropriate locations with the device I invented, it is possible to capture and extract these pathogens and genes from the bodies of humans and animals, and to extract pathogens from water and air in the living environment. can.

I also invented an innovative procedure I call local loopback. It takes a small 1mL sample of a patient's blood and kills any pathogens in the sample. The dead pathogen is then injected or looped back into the same patient, along with healthy blood of the same type as the patient's blood. The advantage of this method is that the white blood cells encounter the dead pathogen and eliminate it, thus learning the protein structure of the pathogen in the patient's body. Now that the white blood cells have learned this lesson, they are ready to fight against living pathogens. This becomes a vaccine against pathogens. Making serum is similar, but a little more complicated. Additionally, my invention involves hyperactivating the patient's immune system. So far, there are no artificial methods to activate the immune system. I call this method remote loopback. A tiny sample of the donor's healthy skin tissue (about the size of the tip of a biopsy) is placed into the patient's bloodstream along with healthy blood of the same type as the patient's blood. Skin tissue is completely harmless to the patient's body. However, the white blood cells see the donor's skin cells as foreign and attack them. This is communicated to the immune system. The immune system then produces more white blood cells to fight the foreign cells. For example, Covid-19 attacks and kills certain white blood cells, which also kills the pathogen. A new fresh supply of white blood cells is revealed here. Note: The general vaccine and serum procedure is for all pathogens where proteins are encoded in the outer shell of the pathogen, with the exception of only a few pathogens such as the HIV virus. My reasoning is that the protein coding in the virus' outer shell comes from the host's white blood cells, making the pathogen less likely to be detected, and that other types of pathogens than the HIV virus interfere with the immune system at the DNA level. This vaccine or serum cannot prevent or cure these few pathogens.

So far, no treatments exist to combat the pathogens present in the body's tissues and organs. I know many patients who die because pathogens in their blood return from infested organs. C Diff colitis and Covid-19 are prime examples. Ultrasound is almost harmless to the patient's body, but it is deadly to pathogens. It can fight against pathogens such as Covid-19 and C Diff Colitis, which are known to exist in body tissues and organs other than the blood. Ultrasound also eliminates pathogens that devour the body, and also eliminates pathogens that eat cells in the body to create their genome and self-replicate. Therefore, ultrasound kills pathogens and their genomes. Covid-19, which infects the lungs and digestive system, is a prime example of such a pathogen. So this method is included in my patent application. However, this method may require anesthesia, and ultrasound can be very painful.

Abstract The purpose of this patent application is to detect pathogens in the human body, animals, plants, water bodies, and air without blood tests or sampling. We also aim to use innovative methods to eliminate pathogens and oncogenes present in humans and animals. It may also be possible to eliminate pathogens in the air, outdoors, plants, and water bodies. It also aims to activate the body's immune system.

My invention consists of detecting and scanning pathogens using spectral signatures without the need for blood tests. Each molecule and pathogen has a unique spectral signature. I have approached therapeutic problems through the electrostatic properties of pathogens. All known pathogens are negatively charged. Oncogenes have a positive or negative charge. By applying direct current voltage to appropriate locations with the device I invented, it is possible to capture and extract these pathogens and oncogenes from the bodies of humans and animals, and to extract pathogens from water and air in the living environment. I can.

I also devised a procedure called local loopback. Local loopback procedures apply to humans and animals. It takes a small sample of a patient's blood and kills any pathogens in the sample. The dead pathogen is then injected or looped back into the same patient, along with healthy blood of the same type as the patient's. The advantage of this method is that the white blood cells encounter the dead pathogen and eliminate it, thus learning the protein structure of the pathogen in the patient's body. Now that the white blood cells have learned this lesson, they are better prepared to fight live pathogens. This can be used as a vaccine against pathogens. Serums accomplish the same thing, but are a little more complicated. Additionally, my invention involves hyperactivating the patient's immune system. I call this procedure remote loopback, and it works for both humans and animals. A tiny sample of the donor's healthy skin tissue (about the size of the tip of a biopsy) is placed into the patient's blood along with fresh, clean donor blood of the same type as the patient's blood. Skin tissue is completely harmless to the patient's body. However, the white blood cells see the donor's skin cells as foreign and attack them. This is communicated to the immune system. The immune system then has to produce more white blood cells to fight the foreign body. For example, Covid-19 attacks and kills certain white blood cells, which also kills the pathogen. A new fresh supply of white blood cells is revealed here.

Ultrasound is mostly harmless to the patient's body, but deadly to pathogens. Ultrasound is used to eliminate pathogens in organs and tissues of animals and humans. This is an innovative method that can fight against pathogens such as Covid-19 and C Diff Colitis, which are known to exist in body tissues and organs other than blood. Ultrasound also eliminates self-replicating pathogens that feed on body cells and create their own genomes. Therefore, ultrasound also kills the genomes of pathogens. A typical example is Covid-19, which infects the lungs and digestive system. Therefore, this method is included in my patent application. However, ultrasound can be very painful, so anesthesia may be required. It is enough to apply ultrasonic waves to the plants.

Description The purpose of this patent application is to detect disease-causing pathogens in the air of humans, animals, water bodies and living spaces without blood tests or sampling. We also aim to use innovative methods to eliminate pathogens and oncogenes that cause diseases in humans and animals. It can also remove pathogens from the air, plants, and water bodies in your living space. Additionally, it aims to increase the body's immunity.

My invention consists of detection and scanning of disease agents by spectral signatures, without the need for blood tests. Every disease pathogen has a unique spectrum of characteristics. The spectral signals of all known pathogens are stored in a device I call HPC device 1H. After scanning a patient, a processor within HPC Instrument 1H determines whether the observed spectral signature matches a pathogen in the database. If there is a match, the device HPC 1H will alert you that the patient has that particular pathogen in his body. See Figure 1 for this apparatus. The device has an infrared sensor to focus on what is called an organ. The operator observes the monitor to ensure that the representation of that organ is within the limits of the screen. If the patient's organ is not within the limits, the operator adjusts the scanner position or patient position until the organ is within the focus of the monitor. After focusing, the HPC device 1H can irradiate the focused organ with UV or X-rays. I like using ultraviolet light. With just 100 watts of ultraviolet light and 50 watts of X-rays, you can obtain clear spectral images without damaging the patient's body. This two or more emitter powers can cause harm to the patient. Below the two settings above, you may get blurry or low quality spectral images. I prefer ultraviolet light, which is less harmful than X-rays. 1000 scans were performed with 5 seconds of UV irradiation. The spectral signature emitted by the body is observed by HPC Instrument 1H in order to match it with pathogens in the database of HPC Instrument 1H. In the Covid-19 example, organs such as the lungs, respiratory tract, lower gastrointestinal tract, and neural tracts are selected. Your doctor will also decide which organs need to be scanned for pathogens. A scan of the entire arm from the shoulder to the palm of the hand is also done to detect pathogens in the patient's bloodstream. This same scanner is also used to detect pathogens inside animals.

Two other variations of this scanner detection device are introduced in [0009]. HPC Device 1W is used for water and HPC Device 1A is used for air. See Figures 2 and 3. These two devices do not require an infrared scanner or light focusing. HPC instrument 1A can emit ultraviolet and X-rays for spectroscopic analysis. The following text demonstrates the power of emitters. Although other power settings are possible, the following power settings are recommended to improve spectral clarity and not damage the environment. I recommend using less harmful UV light. Choose a 10KW UV emitter. Performs 1000 scans with 5 seconds of light emission. The spectral signature emitted from the air is observed by this instrument, HPC Instrument 1A, and matched against any pathogen in the HPC Instrument 1A's database. HPC Instrument 1A can scan up to 2 miles in all directions. When using X-rays for HPC equipment 1A, the emitter output is 5KW and can detect up to a 2 mile radius. HPC device 1W is for underwater use. If X-ray is selected for HPC equipment 1W, the emitter output is 50KW and can be detected up to a radius of 2 miles. It is possible to enter the water approximately 1 meter below the water surface and scan a hemispherical area up to 2 miles in all directions. It can be submerged to a depth of 1m for higher quality images. The HPC device 1W can irradiate UV and X-rays for underwater spectral analysis. I would like to use ultraviolet light. Selected 100KW UV emitter. We performed 1000 scans with 5 seconds of light emission. The spectrum emitted from water is observed using HPC equipment 1W and compared with pathogens in the database of HPC equipment 1W.

Because pathogens have a negative charge, a pair of plates attached to a DC power source repels the negative pole and captures the positive pole. For water washing of pathogens, a pair of square copper plates were selected after detection with HPC device 1W of [0010]. This plate measures 1m x 1m and is 1 inch thick. One was attached to the positive side of a 100KW power supply, and the other was attached to the negative side of the same power supply. There is a distance of 1m between the two plates. Note: Many pathogens are concentrated near the water surface. Submerge these two plates in water. You can also load these two plates onto a small boat. After the two-hour boat trip, the plates are heated in a 1,000-degree Fahrenheit oven for 20 to 30 minutes to kill any pathogens caught in the water. This process continues until most of the pathogens are removed.

For air purification of pathogens, I chose a pair of square copper plates after detection by HPC device 1W of [0010]. This plate will be 1m x 1m and 1 inch thick. One is attached to the positive side of a 10KW power supply, and the other is attached to the negative side of the same power supply. There is a distance of 1m between the two plates. Load these two plates into a small vehicle such as a pickup truck. After 2 hours, heat the plate in a 1000 degree Fahrenheit oven for 20 to 30 minutes to kill any airborne germs. This process continues until most of the pathogens are removed.

I have approached treatment using the electrostatic properties of disease-causing pathogens. All known pathogens are negatively charged. Genes that cause cancer have either a positive or negative charge. Some amoeba are positively charged and others are negatively charged. By applying a direct current voltage to the appropriate plates of the device described in this paragraph, it is possible to capture and remove these pathogens and carcinogenic genes from the human or animal body, or to remove pathogens from water or air in the living environment. You can do that.
See Figure 4 for HPC device 2. A pint of blood is drawn from the patient and placed in a vial that is below the level of the bed. In this method, after the nurse starts drawing blood, it flows into the bottle 10 by gravity. Bottle 10 has an opening at the top and blood flows into bottle 10 through the phlebotomy hose. This continues until the lid of jar 10 is completely in contact with the blood. At this time, the phlebotomy valve is turned, stopping the flow of blood into bottle 10. To compensate for fluid loss, white blood cell loss, and plasma loss, 1000 mg of vitamin C is administered, and concurrently with treatment, the patient is receiving water and plasma infusions. Jar 10 is made of copper-aluminum alloy. This bottle is processed to have pores of different sizes depending on the disease, using an anodizing process that is typically used for industrial purposes. A special alumite treatment method is required, as described in paragraph [0014]. The lids of these bottles are usually not anodized unless you are dealing with amoeba diseases. Use a dielectric material such as flexible plastic to prevent contact between the lid and the jar. The lid is connected to the negative side of a DC power source, and the bottle body is connected to the positive side of the same power source. The power supply has two modes, 25V and 50V, and in any case, the best total output is 100W. At 25V, it is thought that it will take about 24 hours to completely drain the blood. At 50V setting, it takes 12 hours to do the same. However, the 25V setting is healthier for patients. The electrostatic properties of the pathogen and its genome are used to capture the pathogen. Pathogens and their genomes are negatively charged in all known pathogens. Apparently, pathogens and their genomes are attracted to the walls of the jar, including the bottom wall, while the lid of the jar 10 repels them. As described in paragraph [0014], by anodizing, the pores inside bottle 10 are made twice as large as possible pathogens. For example, if the size of the hypothetical pathogen is 150 nm, the pores created inside the bottle 10 are selected to be 300 nm. In AIDS and similar diseases, pathogens invade some white blood cells. In that case, an anodized vial with pores twice the size of the contaminated leukocytes should be added. Naturally, white blood cells are negatively charged. For this category of pathogens, these invading leukocytes will be attracted to the holes in the vial 10 and become trapped. For this type of pathogen, it is highly recommended to first capture the invading white blood cells, and then pour the contents of the jar into another jar with specific pores twice the size of the pathogen . At this point, the invading white blood cells and targeted pathogens are trapped in the pores of the two vials by electrostatic forces. The contents of the final bottle are free of pathogens and invading white blood cells. The contents of this bottle are poured into a blood dispenser to be injected into the patient's artery. Now, it's time to get rid of the pathogen. So far, the No. 10 bottle, no matter the hole size, is connected to direct current electricity, which prevents pathogens from escaping due to electrostatic forces. When there is finally no more blood in the bottle, the contaminated bottle can be heated at 1000 degrees Fahrenheit for about half an hour to eliminate pathogens. Of course, thin plastic insulation must be disposed of properly. Again, use a new bottle (set of 2 for the aid) and repeat the above steps.
[0002]'s HPC device 1H scans the area from the shoulder to the border of the arm by hand, and if the spectrum of the detected pathogen does not appear on the monitor, no pathogen is detected in the blood. Although it is good to take a small amount of blood from the patient, routine examination under a microscope can be misleading. It is very inconvenient to collect enough blood to view it under a microscope. If no pathogen is found in bottle 10 in HPC device 1H of [0002], electrostatic cleaning of the blood in bottle 10 is continued for 4 more bottles. This is when pathogens can be hiding in strange places. Before sending the patient home, it is a good idea to double check with appropriate blood tests and check with HPC machine 1H at [0002]. Also, for diseases where pathogens are hidden in tissues or organs, such as coronavirus or hepatitis C, please refer to [0015], that is, HPC device 3 and HPC device 4 in [0023].

Anodizing (anodizing or anodizing) is a known industrial process. To custom design this invention, I selected some special considerations to suit the purpose of trapping pathogens. In this way, this industrial process can have new uses and therefore nobility for medicine. The anodizing highlights of this invention are as follows: I chose the following alloy, copper aluminum/doping. The reason for alloying/doping is to create larger than normal pores when needed. Make a cubic bottle with a capacity of 1 pint from this alloy. Before this alloy is anodized and formed into cubic bottles, it is first degreased and then electropolished to smooth the surface of the plate. It also ionizes when necessary to create indentations in the copper and aluminum alloy, creating larger pores. The maximum pore size without ionization is 750 nm. For example, if white blood cells are infected with the AIDS virus, a larger pore size is required to match the size of the infected white blood cells. White blood cells are larger than 750nm. In this way, negatively charged white blood cells infected with the AIDS virus are attracted by electrostatic force and become trapped in the hole in the bottle, where they can be stored until they are incinerated. Also, the longer the anodizing process takes, the larger the pores will be.

For HPC device 3, see Figure 5. This device uses the electrostatic properties of pathogens and their genomes to capture them. If recommended by a doctor or if Device 1 HPCH recognizes a pathogen or its genome in a tissue or organ, HPC Device 3 can extract the pathogen or its genome. This device consists of two needles, similar to the needles of a syringe. These needles are made from an alloy of tungsten, available from several specialty vendors, and are 36 gauge. Both needles are 5 inches long. There are 5 small grooves at the tip of one of the two needles. These five grooves have a 45 degree angle to the body of the needle. These five grooves go into the main hollow track of the needle. This groove was created by a specialist using a fine beam laser. This needle is attached to the positive part of the power supply. The body of this needle is rough, both the inside of the five grooves and the main track of the needle are rough. This is because negatively charged pathogens and genomes are attracted to the positive needle and attach to it, and we want to prevent them from detaching while attached. The other needle is simple, with no main track or groove inside, and a smooth surface. This needle is connected to the negative side of the power supply. The voltage setting for the power supply is set to either 25V or 50V. However, it operates on voltages between 25V and 100V. Anything above 100V is unhealthy for the patient. It has no effect below 25V. The output of the power supply is 100W at 50 volts and 50W at 25 volts. I would like to use the 50V option. This option is more effective. After blood purification by HPC device 2, if the HPC device 4 described in [0023] fails to kill the pathogen in the organ with ultrasound, the pathogen and its genome can be extracted by HPC device 3 after one month, for example. . This method uses the two needles mentioned above to make an incision within 2 mm. Determine the approximate location of the pathogen and its genome with HPC equipment 1H. HPC device 3 can catch possible pathogens and their genomes by electrostatically attracting negatively charged pathogens and genomes to a needle attached to the positive side of the power supply. Generally speaking, there is no problem with the incision location as long as it is within 2mm. In addition, a repulsive force acts between the needle attached to the negative side of the power source and the pathogen or genome. This repulsive force makes the positive needle more likely to attract pathogens and genomes. If possible, it is best to make an incision so that the pathogen or genome is between the two needles. However, using this device, it is also possible to extract the genome in one piece. This method is relatively painless and harmless. Usually, it takes about 10 tries to extract the genome at once. Note: When working with organs, you may need medications to reduce swelling and inflammation. Genomes and pathogens may be grown in the lab and frozen at -60 degrees Fahrenheit for later use.

Please note that I believe that the best treatment for pneumonia is this device 3HPC. After applying the device 4HPC mentioned in [0023], if there is still an infection as directed by the HPC device 1H, the incision associated with this device 3HPC seems to be the best option.

In my experience, the best treatment for cancer is this HPC device3. If the cancer has progressed, it cannot be cured. It is best to start this treatment when the cancer is in its early stages, or when the cancer is mild.
Even moderately advanced cancers can be treated with this therapy. Malignant tumors cannot be treated or tested using this treatment method. The power supply used is 50 volts and 100 watts output. Any other voltage or power may not work or cause more damage. Begin the incision at the location of the appearance of the cancer. For example, in the liver, cancer cells usually cause swelling in patches of the liver. That spot becomes the starting point for the incision. Also, there are positive and negative genes that cause cancer. Therefore, the two needles are the same type as the needle on the positive side of this device in [0015]. Both hands have a rough surface on the inside of the five grooves. Both hands have a rough surface on the inside of the main track. The outer surface of both hands is rough. The reason for the rough surface is as explained previously. If you look at the voltage indicator on the power supply, you will see spikes and very small voltage drops. This voltage drop is in microvolts. At this time, we know that we have caught a cancer gene. The incision lasts about 10 hours and frees most of the organ from the cancer gene. You know you're in the vicinity when you see a spike in voltage drop. Continue making incisions around this area until there are no more power spikes, about 5 times. Note that X-rays may be the best way to find the focus of cancer. As mentioned above, it is impossible to completely free an organ from cancer genes, but this is a very good start. Also, it cannot be said that 10 hours after inserting a needle into an organ is not harmful. However, this method is significantly superior to traditional surgery. Another great advantage of this surgery is that the needle injury is very small, so with medical treatment, nutrition, and rest, the needle biopsy scar will heal over time. This method can be repeated on average every 6 months. The above is an example of the liver, but it can be used for all soft tissue organs. In the case of brain tumors, this procedure can be performed 3 months after surgery after the tumor has been removed. Again, check for spikes or voltage drops on the power supply. An incision is made centered on the location of the tumor. This treatment for cancer cannot be done on bones.

For leukemia, all leukocyte-related organs such as the spleen and thymus are checked, i.e. checked by HPC device 3 and the corresponding spike in the power supply is checked. For spikes, treat that organ with the same device. Use the remote loopback procedure described in paragraph [0022]. This is what produces some bone marrow and white blood cells to replace and replace the damaged ones. However, it may not be suitable for advanced cancer cases. In any case, the white blood cells and bone marrow created may at least reduce the need for donor bone marrow. The remote control loopback described in [0021] is very effective. This can be done on the same day as any cancer treatment. After treatment has been performed on the patient, the needles are sterilized by temperatures between 500 and 1000 degrees Fahrenheit. I chose 550 degrees Fahrenheit. Caution: Cancer is known to progress and move to other parts of the body even after surgery or other cancer treatments. After the cancer treatment mentioned in this paragraph, it is recommended to perform a random check of various parts of the body with an HPC device3. More importantly, use a bottle similar to bottle 10 in [0014] of HPC device 2 for blood checks. Here again, voltage drop spikes in the power supplies of HPC device 2 and HPC device 3 are monitored to check for cancer spots or genes in the blood. For cancer, especially leukemia, we recommend starting with Instrument 2 HPC. I would like to capture genes in the blood and also capture cells where genes are infested. In this case, the jar is in two halves, one connected to the positive side of a 100 watt, 50 volt power source, and the other to the negative side. This is separated by a dielectric material such as plastic. This allows the infested blood cells and genes to be taken in. Naturally, the pore size is twice the size of the largest blood cell in question. It is clear that plasma transfusions are very effective, especially in cases of leukemia. At the same time, the HPC device 3 is also used to look for cancer in other organs that may not have started inflammation or swelling.

As an option, a fine magnetic coil is wrapped around each of the two needles for the HPC device 3, and a DC voltage is applied to the coil. Coils are not recommended for this device as they are somewhat harmful to the patient and this method is very inefficient.

Currently, surgeons must use extremely abrasive procedures to extract the genome of a pathogen in an organ. This polishing procedure is similar to a biopsy, but the surgeon uses a needle to dig into the tissue and extract the genome. Naturally, a large number of cells are pulled out along with their genomes.
The genome can also be damaged due to procedures like this biopsy. This procedure is not performed on living patients. Using HPC equipment 3 in paragraph [0015] is also excellent here as it allows extraction of the whole genome with minimal damage to the patient.

I also devised a method called local loopback. This serum and vaccine production method is only applicable to pathogens that have a protein code embedded in their outer shell. Covid-19 is an example of this category. Local loopbacks are useful for both Covid-19 serums and vaccines. This serum and vaccine are not effective against AIDS. It takes a small 1 mL sample of a sick patient's blood and kills any pathogens in the sample.
Care must be taken to ensure that the protein coding is not compromised. The dead pathogen is then injected into the patient, either intravenously or looped back, along with a pint of healthy blood of the same type as the patient's. This is vaccine treatment. For serum, four more stages are required. The first stage uses a pathogen that has grown inside the cells of an organ, along with a completely killed genome. The next four stages require completely dead pathogen, 3/4 dead pathogen, 1/2 dead pathogen, and 1/4 dead pathogen. Pathogens that are completely killed are no longer active. A quarter-killed pathogen is close to being fully activated. 1/2 dead pathogen is not dangerously active. 3/4 dead pathogens have almost no activity. I have achieved killed or slightly killed pathogens using a laboratory type microwave. The four additional stages of serum are as follows: Stage 1: Two days after vaccination, one pint of healthy donor blood of the same blood type as the patient contains 90% completely dead pathogens and 10% 3/4 dead pathogen, and if the pathogen grows inside the cells of an organ, we use a mixture of completely dead pathogen along with the fully dead genome of that pathogen. Stage 2: Two days after stage 1, a pint of healthy donor blood of the same type as the patient's blood contains 90% of the complete dead genome of a pathogen, when that pathogen multiplies within the cells of an organ, 3 /4 Use a mixture of 5% dead and 5% half-dead genomes. Stage 3: 2 days after Stage 2, using a mixture of 90% complete cadavers, 5% 3/4 cadavers, 5% half cadavers, and 20 counts of 1/4 cadaver pathogens. Stage 4: Two days after stage 3, one pint of healthy donor blood of the same type as the patient's blood contains 90% completely dead bacteria, 3/4 dead bacteria 5%, half dead bacteria 5%, and 1/4 dead bacteria. We use a 20-count mixture that, when the pathogen multiplies in the cells of the organ, also completely kills the genome of the pathogen. The advantage of this method is that the white blood cells encounter and eliminate the dead pathogen and its dead genome, and in this way the white blood cells learn the protein structure of the pathogen in the patient's body. Now that the white blood cells have learned this lesson, they are better prepared to fight live pathogens. Serum takes 7 months to ensure that no pathogens are present in the patient's blood. Three months after stage 4 serum treatment, if there are any symptoms, start serum treatment again. If the pathogen is present in the tissues of the organ, the disease will obviously begin again. In my experience, four additional uses of the serum will cure the disease. Therefore, the instructions for using this serum are as follows: After the first use, wait for 3 months. If you still have symptoms of the disease, an additional dose of the serum four times every month should cure it. For vaccination, the pathogen is obtained from a sick patient. Please refer to the next paragraph for better results. I use a procedure I call remote loopback.
Also, adding a completely dead genome to the serum gives better results. Also, in paragraph [0022] we introduced a procedure called remote loopback, and when this procedure is used in conjunction with the serum mentioned above, extremely good results can be obtained. It is recommended to take 1000mg of vitamin C for several days after serum injection. Vitamin C is known to promote white blood cell production.

Remote Loopback: My invention involves hyperactivating the patient's immune system.
I call this procedure remote loopback. This method is effective when used at the same time as vaccination and serum application. Vitamin C is known to increase the number of white blood cells, which appears to be very effective. A small amount of skin tissue (about the size of the tip of a biopsy) from a healthy donor is placed in a pint of healthy donor blood of the same type as the patient's blood. This pint of blood is placed into the patient's body through an IV drip. Skin tissue is harmless to the patient's body. However, white blood cells recognize the body as foreign and attack the donor's skin cells. This is communicated to the immune system. The immune system then has to produce more white blood cells to fight the foreign cells. For example, Covid-19 attacks and kills certain white blood cells, and this attack also kills the pathogen. Again, it is clear that a new, fresh supply of white blood cells is needed.

HPC device 4: Ultrasound is almost harmless to the patient's body, but deadly to pathogens. It can fight against pathogens such as Covid-19 and C Diff Colitis, which are known to be present in body tissues and organs other than blood. Ultrasound also eliminates self-replicating pathogens that feed on body cells and create their own genomes. Therefore, ultrasound also kills the genomes of these pathogens. The best example of this is Covid-19, which infects the lungs, respiratory system, and digestive system. So this method is included in my patent application. However, ultrasound is very painful and requires general anesthesia. Please see Figure 6 for the ultrasound diagnostic device that I invented. I call this HPC equipment 4. The output of HPC device 4 is 100 watts. For example, let's say you want to kill the Covid-19 virus and its genome, which is infested in several parts of your lungs. Note that the Covid-19 genome has a different spectrum than the spectrum of the Covid-19 virus as a whole. HPC device 1H is used to indicate the invaded spot. In this example, all spots in the lung are processed one at a time. In this example, the metal side of the applicator is placed over the lung location on the skin surface indicated by HPC Device 1H. You rub the metal side of the applicator of HPC device 4 in Figure 5 against the skin area above the problem area. If the neuropathology is infested with pathogens, this ultrasound diagnostic device is also used. Caution: Keep away from spine. Surgery involving HPC device 4 requires general anesthesia. Two hours of ultrasound treatment for each organ is sufficient. When starting ultrasound treatment, it is recommended to wash the blood about half way. This blood was washed by HPC device 2 at [0013]. This mechanism is used because there is even the slightest possibility that the virus in an organ or patient's blood could transfer from the organ to the blood, or vice versa. After cleaning the lungs for Covid-19 and cleaning the blood for viruses, we recommend checking for Covid-19 and genomic signatures using the HPC instrument 1H in this example. If these signs occur, the blood and organ cleansing will be repeated. This continues until all relevant Covid-19 signatures no longer appear on HPC Machine 1H and the last four samples of blood also show no signs of Covid-19. After ultrasound treatment, remote loopback of [0022] can be dramatically effective. Also, anti-inflammatory, and anti-tumor drugs are strongly recommended during the use of this procedure and after a few days, at the discretion of the doctor, to check for allergies to these types of drugs.

HPC device 1H is for detecting pathogens in humans or animals. HPC device 1A detects pathogens in the air. HPC device 1W detects pathogens in the air. HPC device 2 cleans blood from pathogens. HPC equipment 3 HPC equipment 4

Claims (132)

A vaccine that can be used in humans and animals, in which a dead pathogen, its dead genome, and a tip of a biopsy of healthy skin tissue from a donor are combined with a pint of healthy donor blood of the same type as the patient's blood. It is a vaccine administered intravenously into the body; the pathogen and its genome are killed by heating between 500 and 1000 degrees Fahrenheit in a 100W laboratory microwave oven for at least 20 minutes. Its genome is no longer active; this option is my favorite and the best operational of the vaccine claims listed here; it requires damage to the pathogen's protein code. . Said killing of the pathogen according to claim 1, and its genome, can be achieved if any hydrocarbon fueled fire producing oven is used. The vaccine according to claim 1 can be achieved if ultraviolet light is used to kill pathogens and their genomes. The vaccine according to claim 1 can be achieved when X-rays are used to kill pathogens and their genomes. The vaccine according to claim 1 can be achieved when gamma rays are used to kill pathogens and their genomes. The vaccine according to claim 1 can be achieved when infrared radiation is used for killing pathogens and their genomes. 7. The vaccine according to claim 1 can be achieved if any abrasive or harsh chemicals are used to kill the pathogen and its genome. The vaccine according to claim 1 can be achieved if any currently available grade of bleach group is used for killing pathogens and their genomes. The vaccine according to claim 1 can be achieved when any pasteurization machine with or without a vibrator is used to kill the pathogen and its genome. The vaccine according to claim 1 can be achieved when an autoclave set between 500 and 1000 degrees Fahrenheit for at least 20 minutes is used for killing the pathogen and its genome. The vaccine according to claim 1 can be achieved if any concentrated antibody substance is used for killing the pathogen and its genome. The vaccine according to claim 1 can be achieved if any magnetic field device consisting of an electronic self-element with a power supply of 100 watts is used for the killing of pathogens and their genomes. The vaccine according to claim 1 can be achieved using any or all combinations of claims 1 to 12 for the killing of pathogens and their genomes. General serum procedure for all pathogens that encode proteins in the outer shell of the pathogen, the only exception being a very small number of pathogens; this serum can be used for both humans and animals; the serum consists of five stages: ( a) Inject the dead pathogen and its dead genome, as well as the biopsy tip of the donor's healthy skin tissue, intravenously along with a pint of the donor's healthy blood of the same type as the patient's blood. The pathogen and its genome are killed by applying heat in a 100W laboratory microwave oven at 500-1000 degrees Fahrenheit until it is inactive; (b) after 2 days, 90% of the pathogen is completely dead and 10% of the pathogen is dead; /4 Inject the dead pathogen, a biopsy tip of the donor's healthy skin tissue, and a pint of donor healthy blood of the same type as the patient's blood; completely dead pathogen and its dead genome. When processed separately, this is accomplished by heating in a 100W laboratory microwave oven set at 500-1000 degrees Fahrenheit to the point where the pathogen and its genome become inactive and the protein coding of the pathogen is not damaged; Dead pathogens are achieved by heating in a 100W laboratory microwave oven until the pathogens are nearly inactivated and the protein coding of the pathogens is not damaged. (c) After 2 days, introduce a mixture consisting of the treated pathogen and its genome assortment. 90% completely dead pathogens and their completely dead genome groups, 5% 3/4 dead pathogens, and 5% 1/2 dead pathogens, and the tip of the donor's healthy skin tissue biopsy is injected intravenously, and one pint of healthy blood from a donor of the same type as the patient's blood; the completely dead pathogen and its dead genome are grown in a 100-watt laboratory microwave oven at temperatures as low as 500 degrees Fahrenheit. By applying heat of 1000 degrees Fahrenheit, the pathogen and its genome are no longer active, and 3/4 dead pathogens are removed by applying heat of 500-1000 degrees Fahrenheit in a 100 watt microwave. and 1/2 dead pathogens can be treated separately by applying heat to 500-1000 degrees Fahrenheit in a 100-watt microwave until they are near inactive. (d) After 2 days, 90% completely dead pathogen and its dead genome, 5% 3/4 dead pathogen, 5% 1/2 dead pathogen, 20 counts 1/4 dead pathogen, The biopsy tip of the donor's healthy skin tissue is placed into a mixture that is treated intravenously with a pint of the donor's blood of the same type as the patient's blood; here the completely dead pathogen and its dead genome are processed, That is, a completely dead pathogen can be achieved by heating its genome in a 100-watt laboratory microwave oven until the genome is no longer active. 3/4 dead pathogens are achieved by applying heat in a 100 watt laboratory microwave until the pathogen is nearly inactive; 1/2 dead pathogens are achieved by applying heat in a 100 watt laboratory microwave. In addition, the 1/4 dead pathogen is heated in a 100 watt laboratory microwave oven until the pathogen is no longer dangerously active, and almost complete activity of the pathogen is achieved, (e) after 2 days, ( Repeat step d). Said processing of the pathogen of claim 14 and its genome may be accomplished when any hydrocarbon fueled fire generating oven is used. The serum according to claim 14 can be achieved when ultraviolet light is used for processing pathogens and their genomes. The serum according to claim 14 can be achieved when X-rays are used for processing pathogens and their genomes. The serum according to claim 14 can be achieved when gamma rays are used for the treatment of pathogens and their genomes. The serum of claim 14 can be achieved when infrared radiation is used for processing pathogens and their genomes. The serum of claim 14 can be achieved if any abrasive or harsh chemicals are used to treat the pathogen and its genome. The serum of claim 14 can be achieved if all currently available grades of bleaching agents are used for the treatment of pathogens and their genomes. The serum of claim 14 can be achieved when any cold sterilization machine with or without a vibrator is used to kill pathogens and their genomes. The serum of claim 14 can be achieved when an autoclave is used, set between 500-1000 degrees Fahrenheit, for processing pathogens and their genomes. The serum of claim 14 can be achieved if any enriched antibody material is used for the treatment of pathogens and their genomes. The serum of claim 14 can be achieved if any magnetic field generating device including an electronic self-element with a power supply of 100 watts is used to treat the pathogen and its genome. The serum according to claim 14 can be achieved when a combination of any or all of claims 14 to 25 is used for treating pathogens and their genomes. The HPC device 1H is used to detect pathogens and genomes in the body; an infrared sensor focuses on and observes an organ and irradiates the organ with ultraviolet light; a 100 watt ultraviolet emitter is used in a patient safe area 1000 scans with 5 seconds of UV radiation to observe and explore the unique spectral signature of the pathogen and its genome; the entire arm, from shoulder to hand, may also be scanned to detect pathogens in a patient's blood. The device of claim 27 is used for detecting pathogens in the body of an animal. The apparatus of claim 27 can be achieved if a 50 Watt X-ray emitter is used for the detection of pathogens and their genomes. The device of claim 29 is used for detecting pathogens in the body of an animal. HPC device 2 is used to rectify the patient's blood at a rate of 1 pint per hour; a special anodization method creates the bottles; each pathogen requires a custom-made bottle; DC power is 25V, output is effective when set to 100W; this is done by electrostatic attraction between the jar and the pathogen; it must be sterilized after each use. The device of claim 31 is capable of rectifying blood in 12 hours, the DC power supply is set at 50V, 100W, and each jar is processed in 30 minutes. For pathogens that invade the white blood cells of the body, the device of claim 31 or 32 is used, but before using the jar of claim 31 or 32, designed to trap these white blood cells. Additional special jars need to be applied. HPC equipment 4 uses ultrasound that kills pathogens and their genomes in the body, which is safe for humans, animals and plants; however, ultrasound is extremely painful and requires general anesthesia for animals and humans; The output of the HPC device 4 is 100 watts; the HPC device 1H of claim 27 is used to indicate the location of the intrusion; the metal surface of the applicator of the HPC device 4 of FIG. Rub it on the area; this ultrasound device can also be used in case of pathogen invasion in neuropathic patients; Warning: Avoid the entire spine when using this device; 2 hours of ultrasound on each organ Treatment is sufficient; if there is no allergy to the drug used, anti-inflammatory and anti-tumor may be critical at the discretion of the physician; see remote loopback in claim 37, after ultrasound treatment, remote loop Back may be dramatically effective Pneumonia can be treated with the HPC device 4 according to claim 34, ie using ultrasound therapy on the lungs. For pathogens that infest organs, whether they have a genome or not, such as C Diff Colitis, Corona virus, etc., the device of claim 31 is first used, and the jar used is designed and designed for that specific pathogen. After purifying the blood, the device of claim 34 is used to purify one organ at a time; if the blood cleaning is done half-heartedly in claim 31, then the device of claim 34 is used to purify one organ at a time; Start the ultrasound treatment at 34; there is a small chance that the virus in the organ or in the patient's blood can move from organ to blood or from blood to organ; for example, for covid-19 in the lungs. After purification and viral purification of the blood, it is recommended to check, for example in this example, for covid-19 and genomic signatures using the HPC device 1H of claim 27; the signs of these signatures indicate the purification of the blood and organs. means to repeat. My invention involves hyperactivating the patient's immune system, a method I call remote loopback; It is useful to apply this at the same time as the application; a very small sample of healthy donor skin tissue, about the size of the tip of a biopsy, is instilled into a pint of healthy donor blood of the same type as the patient's blood. The skin tissue is harmless to the patient's body, but the white blood cells detect foreign substances and attack the donor's skin cells, which then informs the immune system. , the immune system has to produce more white blood cells to fight foreign cells; vitamin C is known to increase the number of white blood cells, which is a big help. The device HPC 1A is used for the detection of pathogens in the air, see figure 2; said device is similar to claim 27, only the infrared scanner is omitted and the 10KW ultraviolet emitter is selected; With 5 seconds of light emission, 1000 scans are performed, and the spectral signature emitted from the air is observed by HPC Instrument 1A and matched to any pathogen in Instrument HPC 1A's database; HPC Instrument 1A can be used up to 2 miles a The device of claim 38 is one in which X-rays are selected instead of ultraviolet radiation; if X-rays are selected in the device HPC 1A, the power of the emitter is 5KW and can be detected up to a radius of 2 miles. . For air purification of pathogens after detection by the device HPC1A of claim 38, I choose a pair of square copper plates, which plates are 1 m x 1 m and 1 inch thick; one plate is 10KW The plate is installed on the positive side of the DC power supply, and the other plate is installed on the negative side of the same power supply, there is a distance of 1m between the two plates, and the two plates can be loaded into a small pickup truck; After the two-hour transfer, the plates are heated in an oven at 1,000 degrees Fahrenheit for 20 to 30 minutes to kill any pathogens captured from the air. In the device of claim 40, a magnetic field generator with a strength of 100 megahenries, 100 windings and a DC voltage of 10 K amperes can be used as an alternative; instead of the DC power supply to the plates, the DC A power supply is connected to the winding; obviously, the polarity of the DC power supply in the winding is such that it attracts negatively charged pathogens. The device HPC 1W is used for the detection of pathogens in water; the emitter penetrates to a depth of about 1 meter below the water surface and is able to scan a hemispherical area in all directions; to improve the quality of the spectral image, the emitter can enter underwater up to a depth of 1 meter; a 100KW UV emitter was selected; 1000 scans were performed with 5 seconds of emission; the spectrum emitted from the water was observed with a 1W HPC device; Compare with pathogens in the database of device 1W. 43. The device of claim 42, wherein X-rays are used instead of ultraviolet radiation, the emitter has a power of 50 KW, and is detectable up to a radius of 2 miles. For cleaning pathogens in water bodies, after detection by the HPC device 1W of claim 41 or 42, I chose a pair of square copper plates, which are 1 m x 1 m and 1 inch thick; One plate is installed on the positive side of a 100KW DC power supply, and the other plate is installed on the negative side of the same power supply, with a distance of 1m between the two plates; Note: Most of the pathogens are concentrated near the water surface. Therefore, the two plates can be submerged in water and the two plates can be loaded onto a small boat; after a two-hour boat trip, the plates can be heated in an oven at 1000 degrees Fahrenheit for 20 to 30 minutes and placed in a body of water. The captured pathogens are killed; this process continues until most of the pathogens are removed. In the device according to claim 44, a magnetic field generator with a strength of 10 megahenry, 100 windings and a DC voltage of 1 K ampere can be used as an alternative, providing a DC power supply to the plate. Instead, a DC power source is attached to the windings; obviously, the polarity of the DC power source in the windings is such that it attracts negatively charged pathogens. HPC device 3, see Figure 5, this device uses the electrostatic properties of pathogens and their genomes to capture them, if recommended by Dr. By recognizing the pathogen and its genome, the device 3HPC can extract the pathogen and its genome. This device consists of two needles, similar to a hypodermic needle. These needles are made of tungsten alloy, 36 gauge, and 5 inches long. , this needle is the same as a hypodermic needle; one tip of the needle has five small grooves, and these five grooves are at a 45 degree angle to the body of the needle that goes into it, and the needle into the main hollow track of a syringe like; this needle is attached to the positive polarity part of a power supply that can have a DC voltage between 25 and 100 volts; the body of this needle is rough; The inside of the five grooves and the main track of the needle are similar; the reason for this roughness is that negatively charged pathogens and genomes are attracted to and attach to the needle on the positive side; The other needle is simple, has no main track or groove inside, has a smooth surface, and is connected to the negative part of the power supply; If the HPC device 4 of claim 34 fails to kill the pathogen in the organ with ultrasound after purifying the organ, the HPC of device 3 can extract the pathogen and its genome; A book needle is incised within 2 mm, and the approximate location of the pathogen and its genome is determined using the HPC device 1H of claim 27; It almost repulses the needle; the genome usually comes out in one piece after about 10 tries. Genomes and pathogens can also be cultured in the laboratory, frozen at -60°C, and used at a later date. If the device of claim 34 does not effectively eliminate the infection, use the device of claim 46 for pneumonia; using all precautions set forth in claim 34. Claim 46 for diseases caused by amoeba, where both needles are of the kind used on the positive side of claim 46, since the amoeba may be positively or negatively charged. Use the device; In case of blood contamination, the device of claim 31 can be used; in the case of claim 31, negatively charged amoeba are attracted to the positive side, that is, the body of the bottle, and positively charged amoeba are attracted to the body of the bottle; It is clear that the negative and positive poles of the power supply can be switched at the discretion of the doctor depending on the situation. The best treatment methods for cancer genes are the HPC device 3 of claim 46 and the HPC device 2 of claim 31. Advanced cancers usually cannot be cured, but it may be worth a try. Even moderately advanced cancers can be treated with this method; the power source used is 50 volts and 100 watts; other voltages and powers are ineffective or more damaging; Start the incision at the location of the appearance of cancer, for example, in the case of the liver, usually cancer cells create swelling in a spot on the liver, the spot is the starting point for the incision; the trick is if the cancer-causing gene is positive or negative Make sure that both needles are the same type as the positive side needle of this device; if you look at the voltage indicator on the power supply, you will see voltage spikes and dips in microvolts, but there are no visible So, at this point, you know that the cancer gene has been caught; the incision lasts about 10 hours, and most of the organ is freed from the cancer gene. You know you're in the right place when you see a spike in voltage drop, so try that spot 5 times and continue making the incision until you don't see any spikes in power anymore; X-rays are best for looking for swelling. It may not be possible to completely remove cancer genes from an organ, but this is a very good start; sticking a needle in an organ for 10 hours is still pretty harmless, but this method Much better than traditional surgery; this method can be repeated on average every 6 months, the example above is of the liver, but can be used on all soft tissue organs; Note: Cancer is known to progress and migrate to different parts of the body even after surgery and other cancer treatments; after cancer treatment, it is recommended to perform random checks of different parts of the body with HPC equipment3 Also, voltage drop spikes in the power supply of HPC device 3 are monitored to confirm the presence or absence of cancer gene spots. More importantly, by checking the blood with HPC device 2, genes in the blood may be moving throughout the body. Here again, voltage drop spikes in the power supply of the HPC device 3 or the HPC device 2 of claims 31 and 42 are monitored to identify cancer gene spots or genes floating in the blood. For cancer, especially leukemia, I recommend starting with HPC device 2; you want to catch genes in the blood and catch cells infested with genes. In this case, the jar is in two halves, one connected to the positive side of a 100 watt, 50 volt power source, and the other to the negative side. This is separated using a dielectric material such as plastic. This allows them to take in the infested blood cells and genes. Of course, the pore size is twice the size of the largest blood cell in question. At the same time, 3HPC is used to explore the inside of cancer and organs, but when detecting genes in blood, it is rather strongly recommended to detect blood or plasma; for brain tumors, 3 months after surgery, the tumor Perform this procedure once the tumor has been removed; the incision is still centered around the area where the tumor was to look for power spikes or voltage drops. In the case of leukemia, using the procedure of claim 49 to treat all soft tissue leukocyte-related organs such as the spleen, thymus; after treatment, using the remote loopback method of claim 37 to replace the damaged ones; Create bone marrow and white blood cells to replace; the created bone marrow may at least reduce the need for donor bone marrow. For the device of claim 31, a magnetic field generator with a strength of 2 kilohenries can be used as an alternative; obviously the polarity in the windings is such that it attracts negatively charged pathogens. In the device of claim 32, a magnetic field generator with a strength of 2 kilohenries can be used as an alternative; obviously the polarity on the windings is such that it attracts negatively charged pathogens. In the device of claim 46, a magnetic field generator with a strength of 2 kilohenries can be used as an alternative; a winding wound around the needle; instead of a DC power source being attached to the needle, a DC power source is connected to the winding. obviously a long needle is needed; the polarity of the DC power supply in the winding is obviously such that it attracts negatively charged pathogens. In the device of claim 49, a magnetic field generator with a strength of 2 kilohenries can be used as an alternative; a winding wound around the needle; instead of a DC power supply attached to the needle, a DC power supply Attached to the winding; obviously a long needle is needed; the polarity of the DC power supply in the winding is obviously such that it attracts negatively charged pathogens. The procedure in claim 1 does not introduce the tip of the biopsy volume of skin tissue into the patient's bloodstream. Said killing of the pathogen of claim 55, and its genome, may be accomplished when any hydrocarbon fueled fire generating oven is used. The vaccine according to claim 55 can be achieved when ultraviolet light is used to kill pathogens and their genomes. The vaccine according to claim 55 can be achieved when X-rays are used to kill pathogens and their genomes. The vaccine according to claim 55 can be achieved when gamma rays are used to kill pathogens and their genomes. The vaccine according to claim 55 can be achieved when infrared radiation is used to kill pathogens and their genomes. The vaccine according to claim 55 can be achieved if any abrasive or harsh chemicals are used to kill the pathogen and its genome. The vaccine according to claim 55 can be achieved if any currently available grade of bleach group is used for killing the pathogen and its genome. The vaccine according to claim 55 can be achieved when any pasteurization machine with or without a vibrator is used to kill the pathogen and its genome. The vaccine according to claim 55 can be achieved when an autoclave set between 500-1000 degrees Fahrenheit for at least 20 minutes is used to kill the pathogen and its genome. The vaccine according to claim 55 can be achieved if any concentrated antibody material is used to kill the pathogen and its genome. The vaccine of claim 55 can be achieved if any magnetic field device consisting of an electronic self-element with a power supply of 100 watts is used for the killing of pathogens and their genomes. The vaccine according to claim 55 can be achieved if any or all combinations of claims 55 to 66 are used to kill pathogens and their genomes. The procedure of claim 1 does not introduce the dead genome into the patient's bloodstream. Said killing of the pathogen of claim 68, and its genome, may be accomplished when any hydrocarbon fueled fire producing oven is used. The vaccine according to claim 68 can be achieved when ultraviolet light is used to kill pathogens and their genomes. The vaccine according to claim 68 can be achieved when X-rays are used to kill pathogens and their genomes. The vaccine according to claim 68 can be achieved when gamma rays are used to kill pathogens and their genomes. The vaccine according to claim 68 can be achieved when infrared radiation is used to kill pathogens and their genomes. The vaccine according to claim 68 can be achieved if any abrasive or harsh chemicals are used to kill the pathogen and its genome. The vaccine according to claim 68 can be achieved if any currently available grade of bleach group is used for killing the pathogen and its genome. The vaccine of claim 68 can be achieved when any pasteurization machine with or without a vibrator is used to kill the pathogen and its genome. The vaccine of claim 68 can be achieved when an autoclave set between 500-1000 degrees Fahrenheit for at least 20 minutes is used for killing the pathogen and its genome. The vaccine according to claim 68 can be achieved if any concentrated antibody material is used to kill the pathogen and its genome. The vaccine of claim 68 can be achieved if any magnetic field device consisting of an electronic self-element with a power supply of 100 watts is used for the killing of pathogens and their genomes. The vaccine of claim 68 can be achieved when a combination of any or all of claims 55 to 66 is used for killing pathogens and their genomes. The procedure of claim 1 does not introduce the dead genome or the skin tissue of claim 1 into the patient's bloodstream. Said killing of the pathogen of claim 81, and its genome, may be accomplished when any hydrocarbon fueled fire producing oven is used. The vaccine according to claim 81 can be achieved when ultraviolet light is used to kill pathogens and their genomes. The vaccine according to claim 81 can be achieved when X-rays are used to kill pathogens and their genomes. The vaccine according to claim 81 can be achieved when gamma rays are used to kill pathogens and their genomes. The vaccine according to claim 81 can be achieved when infrared radiation is used to kill pathogens and their genomes. The vaccine of claim 81 can be achieved if any abrasive or harsh chemicals are used to kill the pathogen and its genome. The vaccine of claim 81 can be achieved when any currently available grade of bleach group is used to kill the pathogen and its genome. The vaccine of claim 81 may be achieved when any pasteurization machine with or without a vibrator is used to kill the pathogen and its genome. The vaccine of claim 81 can be achieved when an autoclave set between 500-1000 degrees Fahrenheit for at least 20 minutes is used to kill the pathogen and its genome. The vaccine according to claim 81 can be achieved if any concentrated antibody material is used to kill the pathogen and its genome. The vaccine of claim 81 can be achieved if any magnetic field device consisting of an electronic self-element with a power supply of 100 watts is used for the killing of pathogens and their genomes. The vaccine of claim 81 can be achieved when a combination of any or all of claims 81 to 92 is used for killing pathogens and their genomes. The treatment of claim 14, in the case of skin tissue, does not introduce the tip of the biopsy volume into the patient's bloodstream. Said processing of the pathogen of claim 94 and its genome may be accomplished when any hydrocarbon fueled fire generating oven is used. The serum of claim 94 can be achieved when ultraviolet light is used for processing pathogens and their genomes. The serum according to claim 94 can be achieved when X-rays are used for processing pathogens and their genomes. The serum of claim 94 can be achieved when gamma rays are used for the treatment of pathogens and their genomes. The serum of claim 94 can be achieved when infrared radiation is used for processing pathogens and their genomes. The serum of claim 94 can be achieved if any abrasive or harsh chemicals are used to treat the pathogen and its genome. The serum of claim 94 can be achieved when any currently available grade of bleach group is used to treat pathogens and their genomes. The serum of claim 94 can be achieved when any cold sterilizer with or without a vibrator is used to kill pathogens and their genomes. The serum of claim 94 can be achieved when an autoclave set between 500 and 1000 degrees Fahrenheit is used for processing pathogens and their genomes. The serum of claim 94 can be achieved if any concentrated antibody material is used for the treatment of pathogens and their genomes. The serum of claim 94 can be achieved when any magnetic field generating device including an electronic self-element with a power supply of 100 watts is used to treat the pathogen and its genome. The serum of claim 94 can be achieved when a combination of any or all of claims 94 to 105 is used for treating pathogens and their genomes. 15. The procedure of claim 14 does not introduce the dead genome into the patient's bloodstream. Said processing of the pathogens of claim 107 and their genomes may be accomplished when any hydrocarbon fueled fire producing oven is used. Said serum of claim 107 can be achieved when ultraviolet light is used for processing pathogens and their genomes. The serum of claim 107 can be achieved when X-rays are used for processing pathogens and their genomes. The serum of claim 107 can achieve that gamma rays are used for the treatment of pathogens and their genomes. The serum of claim 107 can be achieved when infrared radiation is used for processing pathogens and their genomes. The serum of claim 107 can be achieved if any abrasive or harsh chemicals are used for processing of pathogens and their genomes. The serum of claim 107 can be achieved when any of the currently available grades of bleaching agents are used to treat pathogens and their genomes. The serum of claim 107 can be achieved when any cold sterilizer with or without a vibrator is used to kill pathogens and their genomes. The serum of claim 107 can be achieved when an autoclave set between 500 and 1000 degrees Fahrenheit is used for processing pathogens and their genomes. The serum of claim 107 can be achieved when any concentrated antibody material is used for the treatment of pathogens and their genomes. The serum of claim 107 can be achieved when any magnetic field generating device including an electronic self-element with a power supply of 100 watts is used to treat the pathogen and its genome. Said serum of claim 107 can be achieved when any or all combinations of claims 107 to 118 are used for treating pathogens and their genomes. The procedure of claim 14 does not introduce the tip of the biopsy volume if skin tissue or introduce dead genome into the patient's bloodstream. Said processing of the pathogen of claim 120 and its genome may be accomplished when any hydrocarbon fueled fire producing oven is used. Said serum of claim 120 can be achieved when ultraviolet light is used for processing pathogens and their genomes. The serum of claim 120 can be achieved when X-rays are used for processing pathogens and their genomes. The serum of claim 120 can be achieved when gamma rays are used for the treatment of pathogens and their genomes. The serum of claim 120 can be achieved when infrared radiation is used for processing pathogens and their genomes. The serum of claim 120 can be achieved if any abrasive or harsh chemicals are used to treat the pathogen and its genome. The serum of claim 120 can be achieved when all currently available grades of bleaching agents are used for processing pathogens and their genomes. The serum of claim 120 can be achieved when any cold sterilizer with or without a vibrator is used to kill pathogens and their genomes. The serum of claim 120 can be achieved when an autoclave is used, set between 500 and 1000 degrees Fahrenheit, for processing pathogens and their genomes. The serum of claim 120 can be achieved when any concentrated antibody material is used for the treatment of pathogens and their genomes. The serum of claim 120 can be achieved when any magnetic field generating device including an electronic self-element with a power supply of 100 watts is used to treat the pathogen and its genome. Said serum of claim 120 can be achieved when a combination of any or all of claims 120 to 131 is used for treating pathogens and their genomes.

Images